Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cytokine Release Syndrome × Leukapheresis × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 6 Glioma 3 Brain Neoplasms 2 Astrocytoma 2 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Recurrence 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lymphoma, Follicular 1 Hepatoblastoma 1 Cytokine Release Syndrome 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

fludarabine 1 Leukapheresis 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02761915 2021-08-17

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Cancer Research UK

Phase 1 Completed

17 enrolled 17 charts

Cytokine Release Syndrome, Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡